![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 20
2022
Ristau, J.; Hoerner-Rieber, J.; Buchele, C.; Klueter, S.; Jaekel, C.; Baumann, L.; Andratschke, N.; Schueler, H. Garcia; Guckenberger, M.; Li, M.; Niyazi, M.; Belka, C.; Herfarth, K.; Debus, J. und Koerber, S. A.
(2022):
Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial.
In: Radiation Oncology, Bd. 17, Nr. 1, 75
Hoegen, P.; Zhang, K. S.; Tonndorf-Martini, E.; Weykamp, F.; Regnery, S.; Naumann, P.; Lang, K.; Ristau, J.; Koerber, S. A.; Dreher, C.; Buchele, C.; Rippke, C.; Renkamp, C. K.; Paul, K. M.; Koenig, L.; Buesch, C.; Krisam, J.; Sedlaczek, O.; Schlemmer, H.-P.; Niyazi, M.; Corradini, S.; Debus, J.; Klueter, S. und Hoerner-Rieber, J.
(2022):
MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
In: Radiation Oncology, Bd. 17, Nr. 1, 59
Pavic, M. 
ORCID: https://orcid.org/0000-0002-3899-6152; Niyazi, M. ORCID: https://orcid.org/0000-0002-7711-9486; Wilke, L.; Corradini, S.; Vornhülz, M.; Mansmann, U. ORCID: https://orcid.org/0000-0002-9955-8906; Al Tawil, A.; Fritsch, R.; Hörner-Rieber, J.; Debus, J.; Guckenberger, M.; Belka, C. ORCID: https://orcid.org/0000-0002-1287-7825; Mayerle, J. und Beyer, G.
(2022):
MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC).
In: Radiation Oncology, Bd. 17, 18
[PDF, 814kB]
ORCID: https://orcid.org/0000-0002-3899-6152; Niyazi, M. ORCID: https://orcid.org/0000-0002-7711-9486; Wilke, L.; Corradini, S.; Vornhülz, M.; Mansmann, U. ORCID: https://orcid.org/0000-0002-9955-8906; Al Tawil, A.; Fritsch, R.; Hörner-Rieber, J.; Debus, J.; Guckenberger, M.; Belka, C. ORCID: https://orcid.org/0000-0002-1287-7825; Mayerle, J. und Beyer, G.
(2022):
MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC).
In: Radiation Oncology, Bd. 17, 18
[PDF, 814kB]
2021
Dapper, H.; Belka, C.; Bock, F.; Budach, V.; Budach, W.; Christiansen, H.; Debus, J.; Distel, L.; Dunst, J.; Eckert, F.; Eich, H.; Eicheler, W.; Engenhart-Cabillic, R.; Fietkau, R.; Fleischmann, D. F.; Frerker, B.; Giordano, F. A.; Grosu, A. L.; Herfarth, K.; Hildebrandt, G.; Kaul, D.; Koelbl, O.; Krause, M.; Krug, D.; Martin, D.; Matuschek, C.; Medenwald, D.; Nicolay, N. H.; Niewald, M.; Oertel, M.; Petersen, C.; Pohl, F.; Raabe, A.; Roedel, C.; Ruebe, C.; Schmalz, C.; Schmeel, L. C.; Steinmann, D.; Stueben, G.; Thamm, R.; Vordermark, D.; Vorwerk, H.; Wiegel, T.; Zips, D. und Combs, S. E.
(2021):
Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations An overview and recommendations of the consortium academic radiation oncology of the German Society for Radiation Oncology (DEGRO).
In: Strahlentherapie und Onkologie, Bd. 198, Nr. 1: S. 1-11
2019
Bauer, J.; Tessonnier, T.; Debus, J. und Parodi, K.
(2019):
Offline imaging of positron emitters induced by therapeutic helium, carbon and oxygen ion beams with a full-ring PET/CT scanner: experiments in reference targets.
In: Physics in Medicine and Biology, Bd. 64, Nr. 22, 225016
Corradini, S.; Alongi, F.; Andratschke, N.; Belka, C.; Boldrini, L.; Cellini, F.; Debus, J.; Guckenberger, M.; Hoerner-Rieber, J.; Lagerwaard, F. J.; Mazzola, R.; Palacios, M. A.; Philippens, M. E. P.; Raaijmakers, C. P. J.; Terhaard, C. H. J.; Valentini, V. und Niyazi, M.
(2019):
MR-guidance in clinical reality: current treatment challenges and future perspectives.
In: Radiation Oncology, Bd. 14, 92
Eder, T.; Hess, A. K.; Konschak, R.; Stromberger, C.; Joehrens, K.; Fleischer, V; Hummel, M.; Balermpas, P.; Grün, J. von der; Linge, A.; Lohaus, F.; Krause, M.; Baumann, M.; Stuschke, M.; Zips, D.; Grosu, A. L.; Abdollahi, A.; Debus, J.; Belka, C.; Pigorsch, S.; Combs, E.; Budach, V und Tinhofer, I
(2019):
Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group.
In: European Journal of Cancer, Bd. 116: S. 67-76
2017
Tessonnier, T.; Mairani, A.; Brons, S.; Haberer, T.; Debus, J. und Parodi, K.
(2017):
Experimental dosimetric comparison of H-1, He-4, C-12 and O-16 scanned ion beams.
In: Physics in Medicine and Biology, Bd. 62, Nr. 10: S. 3958-3982
Chen, W.; Bauer, J.; Kurz, C.; Tessonnier, T.; Handrack, J.; Haberer, T.; Debus, J. und Parodi, Katia
(2017):
A dedicated software application for treatment verification with off-line PET/CT imaging at the Heidelberg Ion Beam Therapy Center.
In: Micro-Mini & Nano-Dosimetry & innovative Technologies in Radiation therapy (Mmnd&Itro2016), Bd. 777, 12021
Mairani, A.; Dokic, I.; Magro, G.; Tessonnier, T.; Bauer, J.; Böhlen, T. T.; Ciocca, M.; Ferrari, A.; Sala, P. R.; Jäkel, O.; Debus, J.; Haberer, T.; Abdollahi, A. und Parodi, Katia
(2017):
A phenomenological relative biological effectiveness approach for proton therapy based on an improved description of the mixed radiation field.
In: Physics in Medicine and Biology, Bd. 62, Nr. 4: S. 1378-1395
Tessonnier, T.; Mairani, A.; Brons, S.; Sala, P.; Cerutti, F.; Ferrari, A.; Haberer, T.; Debus, J. und Parodi, K.
(2017):
Helium ions at the heidelberg ion beam therapy center: comparisons between FLUKA Monte Carlo code predictions and dosimetric measurements.
In: Physics in Medicine and Biology, Bd. 62, Nr. 16: S. 6784-6803
Tessonnier, T.; Böhlen, T. T.; Ceruti, F.; Ferrari, A.; Sala, P.; Brons, S.; Haberer, T.; Debus, J.; Parodi, K. und Mairani, A.
(2017):
Dosimetric verification in water of a Monte Carlo treatment planning tool for proton, helium, carbon and oxygen ion beams at the Heidelberg Ion Beam Therapy Center.
In: Physics in Medicine and Biology, Bd. 62, Nr. 16: S. 6579-6594
Röder, F.; Alldinger, I; Uhl, M.; Saleh-Ebrahimi, L.; Schimmack, S.; Mechtersheimer, G.; Büchler, M. W.; Debus, J. und Ulrich, A.
(2017):
Intraoperative electron radiation therapy in retroperitoneal sarcoma: a retrospective single center analysis of 178 cases.
In: Strahlentherapie und Onkologie, Bd. 193:
S15-S16
Röder, F.; Alldinger, I.; Uhl, M.; Saleh-Ebrahimi, L.; Schimmack, S.; Büchler, M. W.; Mechtersheimer, G.; Debus, J. und Ulrich, A.
(2017):
Intraoperative Electron Radiation Therapy in Retroperitoneal Sarcoma: A Retrospective Single Center Analysis of 178 Cases.
In: International Journal of Radiation Oncology Biology Physics, Bd. 99, Nr. 2, E758-E758
2016
Linge, A.; Lohaus, F.; Löck, S.; Gudziol, V.; Nowak, A.; Neubeck, C.; von Tinhofer, I.; Budach, V.; Sak, A.; Stuschke, M.; Balermpas, P.; Rödel, C.; Avlar, M.; Grosu, A.-L.; Abdollahi, A.; Debus, J.; Bayer, C.; Belka, C.; Pigorsch, S.; Combs, S. E.; Mönnich, D.; Zips, D.; Baretton, G. B.; Buchholz, F.; Baumann, M. und Krause, M.
(2016):
Impact of tumour hypoxia and cancer stem cells on loco-regional control after primary radiochemotherapy in locally advanced HNSCC - results of a multicentre biomarker study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
In: Oncology Research and Treatment, Bd. 39: S. 22-23
Mairani, A.; Dokic, I.; Magro, G.; Tessonnier, T.; Kamp, F.; Carlson, D. J.; Ciocca, M.; Cerutti, F.; Sala, P. R.; Ferrari, A.; Böhlen, T. T.; Jäkel, O.; Parodi, K.; Debus, J.; Abdollahi, A. und Haberer, T.
(2016):
Biologically optimized helium ion plans: calculation approach and its in vitro validation.
In: Physics in Medicine and Biology, Bd. 61, Nr. 11: S. 4283-4299
Tinhofer, I.; Budach, V.; Saki, M.; Konschak, R.; Niehr, F.; Jöhrens, K.; Weichert, W.; Linge, A.; Lohaus, F.; Krause, M.; Neumann, K.; Endris, V.; Sak, A.; Stuschke, M.; Balermpas, P.; Rödel, C.; Avlar, M.; Grosu, A. L.; Abdollahi, A.; Debus, J.; Belka, C.; Pigorsch, S.; Combs, S. E.; Mönnich, D.; Zips, D. und Baumann, M.
(2016):
Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
In: European Journal of Cancer, Bd. 57: S. 78-86
2015
Hoffmann, M.; Saleh-Ebrahimi, L.; Zwicker, F.; Haering, P.; Schwahofer, A.; Debus, J.; Huber, P. E. und Roeder, F.
(2015):
Long term results of postoperative Intensity-Modulated Radiation Therapy (IMRT) in the treatment of Squamous Cell Carcinoma (SCC) located in the oropharynx or oral cavity.
In: Radiation Oncology
10:251
[PDF, 2MB]
2012
Schmidt, J.; Abel, U.; Debus, J.; Harig, S.; Hoffmann, K.; Herrmann, T.; Bartsch, D.; Klein, Justus; Mansmann, Ulrich; Jäger, D.; Capussotti, L.; Kunz, R. und Büchler, M. W.
(2012):
Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma.
In: Journal of Clinical Oncology, Bd. 30, Nr. 33: S. 4077-4083
2005
Knaebel, H. P.; Marten, A.; Schmidt, J.; Hoffmann, K.; Seiler, C.; Lindel, K.; Schmitz-Winnenthal, H.; Fritz, S.; Herrmann, T.; Goldschmidt, H.; Mansmann, Ulrich; Debus, J.; Diehl, V. und Buchler, M. W.
(2005):
Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma CapRI: study protocol [ISRCTN62866759].
In: BMC Cancer
5:37
[PDF, 282kB]